1-(2-Hydroxyethyl)-4-methylpiperazine

We are 1-(2-Hydroxyethyl)-4-methylpiperazine CAS:5464-12-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1-(2-Hydroxyethyl)-4-methylpiperazine
CAS.NO:5464-12-0
Molecular Formula: C7H16N2O
Molecular Weight: 144.21500

Synonyms:
2-(4-methylpiperazin-1-yl)ethanol

Physical and Chemical Properties:
Density: 1.003 g / cm3
Boiling point: 54-55 ° C / 0.5mbar
Melting point: 39-41 ° C
Flash point: 106.1ºC
Refractive index: 1.485

Specification:
Appearance:White  powder
Purity:≥97.0%
Impurity: ≤0.03

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:An important raw material and intermediate used in Organic Synthesis,Pharmaceuticals.

Related News: The measure starts on February 4, according to South Korean Prime Minister Chung Sye-kyun.9-β-D-arabinofuranosylguanine CAS:38819-10-2 The program caused the price of some drugs to plunge more than 90% when it was introduced last year in some cities, state news agency Xinhua said. 7- (4-clorobutoxi) quinolin-2 (1H) -ona CAS:913613-82-8 As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.4-Chloro-3-fluorobenzotrifluoride CAS:32137-20-5 As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself.